Genentech Inc. and partner Biogen Idec Inc. said the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further discussion.
Bristol-Myers Squibb Co. is splitting off its holdings in infant formula maker Mead Johnson Nutrition Co. in order to focus on its biopharmaceutical business.
GlaxoSmithKline PLC and Nabi Biopharmaceuticals said Monday they will work together to develop vaccines to help smokers give up the habit, in a deal that could be worth more than $500 million.
A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Poniard Pharmaceuticals Inc. said its cancer drug candidate picoplatin did not help lung cancer patients live longer, sending its shares plunging in early trading.
Human Genome Sciences Inc. said the Food and Drug Administration will not approve the company's anthrax treatment until it receives additional information on the potential drug.
Pharmaceutical maker Novartis AG said a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.
Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.
Federal health officials said a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
A glowing, eerily beautiful image of a water flea with its radiant green “crown of thorns” took top prize in the 2009 Olympus BioScapes Digital Imaging Competition, a forum for showcasing microscope photos and movies of life science subjects.
Life Technologies Corporation has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
A technical poster from Fluidigm Europe that demonstrates a new approach, which when used in combination with Fluidigm's BioMark real-time PCR system, provides a simple, inexpensive and reproducible solution to single cell gene expression.
Orion Genomics has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG.